Supplementation of atherogenic diet with B vitamins does not prevent atherosclerosis or vascular dysfunction in monkeys

Circulation

Volumn 103, Issue 7, 2001, Pages 1006-1011

  Lentz, Steven R ^a   Piegors, Donald J ^a   Rene Malinow M ^b   Heistad, Donald D ^a  

^a UNIVERSITY OF IOWA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Atherosclerosis; Cholesterol; Endothelium; Homocysteine; Thrombin

Indexed keywords

CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; THROMBIN;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROSIS; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; ILIAC ARTERY; MONKEY; NONHUMAN; PRIORITY JOURNAL; VASCULAR DISEASE;

EID: 0035916266     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.7.1006     Document Type: Article

References (28)

1. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: Probable benefits of increasing folic acid intakes
2. Homocyst(e)ine, diet, and cardiovascular diseases: A statement for healthcare professionals from the Nutrition Committee, American Heart Association
3. Homocyst(e)ine and cardiovascular disease: A critical review of the epidemiologic evidence
4. Total homocysteine and cardiovascular disease
5. Homocysteine metabolism
6. Homocysteine and arteriosclerosis: Subclinical and clinical disease associations
7. The effect of folic acid fortification on plasma folate and total homocysteine concentrations
8. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys
9. Impaired anticoagulant response to infusion of thrombin in atherosclerotic monkeys associated with acquired defects in the protein C system
10. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia
11. Hemodynamic sequelae of regression of experimental atherosclerosis
12. Structural and hemodynamic responses of peripheral arteries of macaque monkeys to atherogenic diet
13. Homocysteine and its disulfide derivatives: A suggested consensus terminology
14. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease
15. Homocyst(e)inemia in daily practice: Levels in coronary artery disease
16. Pyridoxal-5′-phosphate determination by a sensitive micromethod in human blood, urine and tissues: Its relation to cystathioninuria in neuroblastoma and biliary atresia
17. Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model
18. Antithrombotic effects of thrombin-induced activation of endogenous protein C in primates
19. Conversion of thrombin into an anticoagulant by protein engineering
20. Impaired relaxation of the carotid artery during activation of ATP-sensitive potassium channels in atherosclerotic monkeys
21. The oxidant stress of hyperhomocyst(e)inemia
22. Blood coagulation: The thrombin paradox
23. Activated protein C resistance due to a common factor V gene mutation is a major risk factor for venous thrombosis
24. Homocysteine, an atherogenic stimulus, reduces protein C activation by arterial and venous endothelial cells
25. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine
26. An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells
27. Plasma levels of activated protein C in healthy subjects and patients with previous venous thromboembolism: Relationships with plasma homocysteine levels
28. Homocysteine and cardiovascular physiology